HUE044928T2 - Ketamin orális dózisformája - Google Patents
Ketamin orális dózisformájaInfo
- Publication number
- HUE044928T2 HUE044928T2 HUE15715764A HUE044928T2 HU E044928 T2 HUE044928 T2 HU E044928T2 HU E15715764 A HUE15715764 A HU E15715764A HU E044928 T2 HUE044928 T2 HU E044928T2
- Authority
- HU
- Hungary
- Prior art keywords
- ketamine
- dosage form
- oral dosage
- oral
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14165057 | 2014-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE044928T2 true HUE044928T2 (hu) | 2019-11-28 |
Family
ID=50486823
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17186636A HUE060851T2 (hu) | 2014-04-17 | 2015-04-16 | Ketamin orális dózisformája |
HUE15715764 HUE044928T2 (hu) | 2014-04-17 | 2015-04-16 | Ketamin orális dózisformája |
HUE17186622A HUE051264T2 (hu) | 2014-04-17 | 2015-04-16 | Ketamin orális dózisformája |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17186636A HUE060851T2 (hu) | 2014-04-17 | 2015-04-16 | Ketamin orális dózisformája |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17186622A HUE051264T2 (hu) | 2014-04-17 | 2015-04-16 | Ketamin orális dózisformája |
Country Status (8)
Country | Link |
---|---|
US (3) | US10335379B2 (hu) |
EP (4) | EP3287124B1 (hu) |
DK (2) | DK3272338T3 (hu) |
ES (3) | ES2743699T3 (hu) |
FI (1) | FI3287124T3 (hu) |
HU (3) | HUE060851T2 (hu) |
PL (3) | PL3131533T3 (hu) |
WO (1) | WO2015158854A1 (hu) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201802104QA (en) | 2013-03-15 | 2018-05-30 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
US20150118300A1 (en) | 2013-10-31 | 2015-04-30 | Cima Labs Inc. | Immediate Release Abuse-Deterrent Granulated Dosage Forms |
PL3131533T3 (pl) * | 2014-04-17 | 2019-12-31 | Develco Pharma Schweiz Ag | Doustna postać dawkowania ketaminy |
CA2961208A1 (en) | 2014-09-15 | 2016-03-24 | Janssen Pharmaceutica Nv | Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression |
CA3020681A1 (en) | 2016-04-11 | 2017-10-19 | Clexio Biosciences Ltd. | Deuterated ketamine derivatives |
US11723883B2 (en) | 2017-06-23 | 2023-08-15 | Ketabon Gmbh | Hydroxynorketamine for the use in the treatment of depression |
US20200009081A1 (en) | 2017-09-13 | 2020-01-09 | Janssen Pharmaceutica N.V. | Delivery Of Esketamine For The Treatment Of Depression |
US11471415B2 (en) | 2017-10-10 | 2022-10-18 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation and methods of treatment |
US10441544B2 (en) | 2017-10-10 | 2019-10-15 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation |
US10869838B2 (en) | 2017-10-10 | 2020-12-22 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation |
KR20240011237A (ko) | 2017-12-22 | 2024-01-25 | 얀센 파마슈티카 엔브이 | 우울증 치료를 위한 에스케타민 |
CA3103440A1 (en) | 2018-06-27 | 2020-01-02 | Clexio Biosciences Ltd. | Method of treating major depressive disorder |
JP2022504036A (ja) | 2018-10-05 | 2022-01-13 | クレキシオ バイオサイエンシーズ エルティーディー. | 大うつ病性障害を治療するためのエスケタミンの投与計画 |
CA3131929A1 (en) | 2019-03-05 | 2020-09-10 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of depression |
US11324707B2 (en) | 2019-05-07 | 2022-05-10 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
GB2596592A (en) | 2020-07-03 | 2022-01-05 | Alkaloid Ad Skopje | Pharmaceutical formulation |
CN112263572A (zh) * | 2020-11-17 | 2021-01-26 | 厦门大学附属翔安医院 | 右旋***在制备治疗脱髓鞘疾病药物中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723614A (en) * | 1971-01-06 | 1973-03-27 | Ciba Geigy Ag | Maltese-cross scored tablet |
US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
EP1103256A1 (de) | 1999-11-26 | 2001-05-30 | Claudius Dr. med. Böck | Verwendung von Ketamin zur Behandlung von neuroendokriner Immundysfunktion und algogenem Psychosyndrom |
AU2001276608A1 (en) | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
US20100291205A1 (en) * | 2007-01-16 | 2010-11-18 | Egalet A/S | Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse |
DE102007009888A1 (de) | 2007-02-28 | 2008-09-04 | Hermann, Holger Lars, Dr. | Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen |
CN101765582A (zh) | 2007-04-26 | 2010-06-30 | 奥斯拜客斯制药有限公司 | 氘标记的*** |
US20120225949A1 (en) * | 2009-08-14 | 2012-09-06 | Demitri Papalos | Compositions and methods for treating bipolar disorder |
WO2014020155A1 (en) * | 2012-08-02 | 2014-02-06 | Clinpharm Reform Gmbh | Oral transmucosal adminstration forms of s-ketamine |
CA2922507C (en) * | 2013-08-26 | 2022-07-05 | Amorsa Therapeutics, Inc. | Single-layer oral dose of neuro-attenuating ketamine |
PL3131533T3 (pl) * | 2014-04-17 | 2019-12-31 | Develco Pharma Schweiz Ag | Doustna postać dawkowania ketaminy |
-
2015
- 2015-04-16 PL PL15715764T patent/PL3131533T3/pl unknown
- 2015-04-16 HU HUE17186636A patent/HUE060851T2/hu unknown
- 2015-04-16 ES ES15715764T patent/ES2743699T3/es active Active
- 2015-04-16 FI FIEP17186636.1T patent/FI3287124T3/fi active
- 2015-04-16 ES ES17186636T patent/ES2935800T3/es active Active
- 2015-04-16 PL PL17186622T patent/PL3272338T3/pl unknown
- 2015-04-16 HU HUE15715764 patent/HUE044928T2/hu unknown
- 2015-04-16 DK DK17186622.1T patent/DK3272338T3/da active
- 2015-04-16 EP EP17186636.1A patent/EP3287124B1/en active Active
- 2015-04-16 EP EP15715764.5A patent/EP3131533B1/en active Active
- 2015-04-16 EP EP22208637.3A patent/EP4180030A1/en active Pending
- 2015-04-16 ES ES17186622T patent/ES2829279T3/es active Active
- 2015-04-16 WO PCT/EP2015/058318 patent/WO2015158854A1/en active Application Filing
- 2015-04-16 PL PL17186636.1T patent/PL3287124T3/pl unknown
- 2015-04-16 HU HUE17186622A patent/HUE051264T2/hu unknown
- 2015-04-16 EP EP17186622.1A patent/EP3272338B1/en active Active
- 2015-04-16 US US15/304,613 patent/US10335379B2/en active Active
- 2015-04-16 DK DK15715764.5T patent/DK3131533T3/da active
-
2019
- 2019-06-11 US US16/437,467 patent/US11103467B2/en active Active
-
2021
- 2021-08-30 US US17/460,476 patent/US20210386691A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3287124B1 (en) | 2022-11-30 |
EP3287124A1 (en) | 2018-02-28 |
ES2935800T3 (es) | 2023-03-10 |
US20210386691A1 (en) | 2021-12-16 |
EP3272338A1 (en) | 2018-01-24 |
DK3131533T3 (da) | 2019-09-16 |
FI3287124T3 (fi) | 2023-01-13 |
PL3131533T3 (pl) | 2019-12-31 |
ES2743699T3 (es) | 2020-02-20 |
US10335379B2 (en) | 2019-07-02 |
EP4180030A1 (en) | 2023-05-17 |
PL3287124T3 (pl) | 2023-02-20 |
US20170035707A1 (en) | 2017-02-09 |
PL3272338T3 (pl) | 2021-01-11 |
HUE060851T2 (hu) | 2023-04-28 |
US20190290600A1 (en) | 2019-09-26 |
US11103467B2 (en) | 2021-08-31 |
EP3272338B1 (en) | 2020-09-09 |
EP3131533B1 (en) | 2019-06-05 |
EP3131533A1 (en) | 2017-02-22 |
HUE051264T2 (hu) | 2021-03-01 |
DK3272338T3 (da) | 2020-11-02 |
WO2015158854A1 (en) | 2015-10-22 |
ES2829279T3 (es) | 2021-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287437A (en) | Flavociclib solid dosage forms | |
HUE044928T2 (hu) | Ketamin orális dózisformája | |
ZA201700301B (en) | Solid oral dosage form of lipophilic compounds | |
IL249946B (en) | High Dose Strength Rocaprib Tablets | |
GB201419257D0 (en) | Pharmaceutical compositions | |
GB201618482D0 (en) | Pharmaceutical compositions | |
DK3229816T3 (en) | Proton-bindende polymerer til oral administration | |
IL249553A0 (en) | Pharmaceutical preparations | |
ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
IL250817A0 (en) | pharmaceutical preparations | |
IL249151A0 (en) | A preparation for oral administration | |
HRP20181406T1 (hr) | Farmaceutski dozni oblici | |
EP3167870C0 (en) | TAMPER-PROOF ORAL DOSAGE FORM | |
ZA201509174B (en) | An oral medicinal composition | |
GB201415811D0 (en) | Solid dosage form production | |
SG2014014872A (en) | Pharmaceutical compositions | |
GB201408432D0 (en) | Pharmaceutical compositions |